Literature DB >> 35707803

Extensions of empirical likelihood and chi-squared-based tests for ordered alternatives.

M Carmen Pardo1, Ying Lu2, Alba M Franco-Pereira1,3.   

Abstract

Several methods for comparing k populations have been proposed in the literature. These methods assess the same null hypothesis of equal distributions but differ in the alternative hypothesis they consider. We focus on two important alternative hypotheses: monotone and umbrella ordering. Two new families of test statistics are proposed, including two known tests, as well as two new powerful tests under monotone ordering. Furthermore, these families are adapted for testing umbrella ordering. We compare some members of the families with respect to power and Type I errors under different simulation scenarios. Finally, the methods are illustrated in several applications to real data.
© 2020 Informa UK Limited, trading as Taylor & Francis Group.

Entities:  

Keywords:  Empirical likelihood test statistic; chi-squared test statistic; distribution-free; stochastic ordering; umbrella ordering

Year:  2020        PMID: 35707803      PMCID: PMC9041694          DOI: 10.1080/02664763.2020.1796944

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.416


  8 in total

1.  Trend tests for case-control studies of genetic markers: power, sample size and robustness.

Authors:  B Freidlin; G Zheng; Z Li; J L Gastwirth
Journal:  Hum Hered       Date:  2002       Impact factor: 0.444

2.  A comparison of tests for restricted orderings in the three-class case.

Authors:  Todd A Alonzo; Christos T Nakas; Constantin T Yiannoutsos; Sherri Bucher
Journal:  Stat Med       Date:  2009-03-30       Impact factor: 2.373

3.  Empirical likelihood based tests for stochastic ordering under right censorship.

Authors:  Hsin-Wen Chang; Ian W McKeague
Journal:  Electron J Stat       Date:  2016-09-08       Impact factor: 1.125

4.  A robust two-stage design identifying the optimal biological dose for phase I/II clinical trials.

Authors:  Yong Zang; J Jack Lee
Journal:  Stat Med       Date:  2016-08-18       Impact factor: 2.373

5.  A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer.

Authors:  Karen L Reckamp; Kostyantyn Krysan; Jason D Morrow; Ginger L Milne; Robert A Newman; Christopher Tucker; Robert M Elashoff; Steven M Dubinett; Robert A Figlin
Journal:  Clin Cancer Res       Date:  2006-06-01       Impact factor: 12.531

6.  NONPARAMETRIC TESTING FOR MULTIPLE SURVIVAL FUNCTIONS WITH NON-INFERIORITY MARGINS.

Authors:  Hsin-Wen Chang; Ian W McKeague
Journal:  Ann Stat       Date:  2018-11-30       Impact factor: 4.028

7.  Efficiency of two sample tests via the restricted mean survival time for analyzing event time observations.

Authors:  Lu Tian; Haoda Fu; Stephen J Ruberg; Hajime Uno; Lee-Jen Wei
Journal:  Biometrics       Date:  2017-09-12       Impact factor: 2.571

8.  Empirical likelihood-based tests for stochastic ordering.

Authors:  Hammou El Barmi; Ian W McKeague
Journal:  Bernoulli (Andover)       Date:  2013       Impact factor: 1.595

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.